Outcomes of children with juvenile idiopathic arthritis receiving biological disease-modifying anti-rheumatic drugs: a retrospective single-centre experience from IndiaResearch in context
Summary: Background: We aimed to study the outcomes (remission, flare and adverse events) of biological disease-modifying anti-rheumatic drugs (bDMARD) in children with JIA from a low-middle-income country setting, and explore the factors associated with these outcomes. Methods: The Pediatric Rheum...
Saved in:
| Main Authors: | Pavneet Kaur, Farheen Kizhakkeveettil Saheer, Bala Siva Rama Krishna J, Banoth Sreeshanth, Ayisha Kavil Peedika, Bareddy Sai Thrisha Reddy, Ashish Datt Upadhyay, Rakesh Lodha, Sushil Kumar Kabra, Narendra Bagri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | The Lancet Regional Health - Southeast Asia |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772368225000836 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
by: Zoltán Kaló, et al.
Published: (2017-01-01) -
Aging does not impact safety and efficacy of biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
by: Yasemin Tombak, et al.
Published: (2025-06-01) -
Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY)
by: Hideto Kameda, et al.
Published: (2025-03-01) -
Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world data
by: Delphine Bertrand, et al.
Published: (2025-07-01) -
Tuberculosis infection in patients with rheumatic diseases under different treatments
by: Tianhui Liu, et al.
Published: (2025-05-01)